Literature DB >> 12913356

Molecular anatomy of Tupaia (tree shrew) adenovirus genome; evolution of viral genes and viral phylogeny.

Udo Bahr1, Eva Schöndorf, Michaela Handermann, Gholamreza Darai.   

Abstract

Adenoviruses are globally spread and infect species in all five taxons of vertebrates. Outstanding attention is focused on adenoviruses because of their transformation potential, their possible usability as vectors in gene therapy and their applicability in studies dealing with, e.g. cell cycle control, DNA replication, transcription, splicing, virus-host interactions, apoptosis, and viral evolution. The accumulation of genetic data provides the basis for the increase of our knowledge about adenoviruses. The Tupaia adenovirus (TAV) infects members of the genus Tupaiidae that are frequently used as laboratory animals in behavior research dealing with questions about biological and molecular processes of stress in mammals, in neurobiological and physiological studies, and as model organisms for human hepatitis B and C virus infections. In the present study the TAV genome underwent an extensive analysis including determination of codon usage, CG depletion, gene content, gene arrangement, potential splice sites, and phylogeny. The TAV genome has a length of 33,501 bp with a G+C content of 49.96%. The genome termini show a strong CG depletion that could be due to methylation of these genome regions during the viral replication cycle. The analysis of the coding capacity of the complete TAV genome resulted in the identification of 109 open reading frames (ORFs), of which 38 were predicted to be real viral genes. TAV was classified within the genus Mastadenovirus characterized by typical gene content, arrangement, and homology values of 29 conserved ORFs. Phylogenetic trees show that TAV is part of a separate evolutionary lineage and no mastadenovirus species can be considered as the most related. In contrast to other mastadenoviruses a direct ancestor of TAV captured a DUT gene from its mammalian host, presumably controlling local dUTP levels during replication and enhance viral replication in non-dividing host tissues. Furthermore, TAV possesses a second DNA-binding protein gene, that is likely to play a role in the determination of the host range. In view of these data it is conceivable that TAV underwent evolutionary adaptations to its biological environment resulting in the formation of special genomic components that provided TAV with the ability to expand its host range during viral evolution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12913356     DOI: 10.1023/a:1025120418159

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  75 in total

1.  High resolution scanning and three-dimensional reconstruction of cellular events in large objects during brain development.

Authors:  Malte Süss; Stefan Washausen; Hans-Jürg Kuhn; Wolfgang Knabe
Journal:  J Neurosci Methods       Date:  2002-01-30       Impact factor: 2.390

2.  Characterization of novel Alu- and tRNA-related SINEs from the tree shrew and evolutionary implications of their origins.

Authors:  Hidenori Nishihara; Yohey Terai; Norihiro Okada
Journal:  Mol Biol Evol       Date:  2002-11       Impact factor: 16.240

3.  Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3.

Authors:  P S Reddy; N Idamakanti; A N Zakhartchouk; M K Baxi; J B Lee; C Pyne; L A Babiuk; S K Tikoo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Complete DNA sequence of canine adenovirus type 1.

Authors:  M D Morrison; D E Onions; L Nicolson
Journal:  J Gen Virol       Date:  1997-04       Impact factor: 3.891

5.  The nucleotide sequence of the early region of the Tupaia adenovirus DNA corresponding to the oncogenic region E1b of human adenovirus 7.

Authors:  R M Flügel; H Bannert; S Suhai; G Darai
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  Analysis and characterization of the complete genome of tupaia (tree shrew) herpesvirus.

Authors:  U Bahr; G Darai
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses.

Authors:  H van Ormondt; J Maat; R Dijkema
Journal:  Gene       Date:  1980-12       Impact factor: 3.688

8.  The complete nucleotide sequence of porcine adenovirus serotype 5.

Authors:  Miklós Nagy; Éva Nagy; Tamás Tuboly
Journal:  J Gen Virol       Date:  2001-03       Impact factor: 3.891

9.  Human dUTP pyrophosphatase: uracil recognition by a beta hairpin and active sites formed by three separate subunits.

Authors:  C D Mol; J M Harris; E M McIntosh; J A Tainer
Journal:  Structure       Date:  1996-09-15       Impact factor: 5.006

10.  Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins.

Authors:  C Stephens; E Harlow
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  4 in total

1.  Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.

Authors:  Hideyo Ugai; Anton V Borovjagin; Long P Le; Minghui Wang; David T Curiel
Journal:  J Mol Biol       Date:  2006-12-06       Impact factor: 5.469

2.  Networks, trees, and treeshrews: assessing support and identifying conflict with multiple loci and a problematic root.

Authors:  Trina E Roberts; Eric J Sargis; Link E Olson
Journal:  Syst Biol       Date:  2009-06-09       Impact factor: 15.683

Review 3.  The tree shrew as a model for infectious diseases research.

Authors:  Runfeng Li; Mark Zanin; Xueshan Xia; Zifeng Yang
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

4.  The tree shrew provides a useful alternative model for the study of influenza H1N1 virus.

Authors:  Zi-feng Yang; Jin Zhao; Yu-tong Zhu; Yu-tao Wang; Rong Liu; Sui-shan Zhao; Run-feng Li; Chun-guang Yang; Ji-qiang Li; Nan-shan Zhong
Journal:  Virol J       Date:  2013-04-10       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.